semaglutide or liraglutide for weight loss vs vs GLP-1 Liraglutide vs Semaglutide vs GLP-1

Fontana L, Klein S, Holloszy JO, Premachandra BN

Clinical trials conducted in the early 2000s showed modest results, and the compound failed to demonstrate sufficient efficacy to support regulatory approval as a weight-loss medicine

Lillys Mounjaro (Tirzepatide), a GIP/GLP-1 Dual Agonist, Demonstrated Cardiovascular Protection in Landmark Head-to-Head Trial, Reinforcing Its Benefit in Patients with Type 2 Diabetes and Heart Disease (Eli Lilly and Company, accessed 19 August 2025)

He explains the most common symptoms including changes in mood, sleep patterns and food cravings and offers his top five tips for how to cope with the impacts of SAD

Dizziness or fainting: This can happen due to a sudden drop in blood pressure, which is a sign of danger

The most common side effects of semaglutide are nausea, vomiting, constipation, and diarrhea